This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Lisinopril in the prophylaxis of migraine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

A double blind, placebo controlled, crossover study enrolled 60 patients to investigate the efficacy of lisinopril in the prophylaxis of migraine.

Patients had >2 migraines, with our without aura, per month.

55 were treated and 47 complied properly with the trial.

Reference:

  • 1) Schrader, H, Stovner, LJ, et al. (2001). Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ, 322, 19-22.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.